+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Droxidopa"

From
Global Orthostatic Hypotension Drugs Market 2022-2026 - Product Thumbnail Image

Global Orthostatic Hypotension Drugs Market 2022-2026

  • Report
  • March 2022
  • 120 Pages
  • Global
From
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Droxidopa is a synthetic amino acid used to treat symptomatic neurogenic orthostatic hypotension (NOH) in adults. It is a cardiovascular drug that works by increasing the levels of norepinephrine, a neurotransmitter that helps regulate blood pressure. It is available in capsule form and is taken orally. Droxidopa is used to treat the symptoms of NOH, such as dizziness, lightheadedness, and fatigue. It is also used to improve quality of life in patients with NOH. It is not recommended for use in patients with severe hypertension or heart failure. The Droxidopa market is composed of pharmaceutical companies that manufacture and distribute the drug. These companies are involved in research and development, manufacturing, marketing, and distribution of the drug. They also provide support services such as patient education and counseling. Some companies in the Droxidopa market include Lundbeck, Jazz Pharmaceuticals, and Avanir Pharmaceuticals. Show Less Read more